On Tuesday, Tyco International PLC (NYSE:TYC)’s shares inclined 2.74% to $36.38.
Tyco (TYC) Chief Executive Officer George R. Oliver will speak at Morgan Stanley’s third annual Laguna Conference in Laguna Beach, Calif., on Thursday, Sept. 17, 2015, at 8:10 a.m., Pacific Time. A live webcast of the presentation and supporting materials will be accessible on the company’s website at: http://investors.tyco.com/.
Tyco International Ltd. designs, sells, installs, and services security, fire detection, suppression, and life safety products worldwide. It operates in three segments: North America Installation & Services, Rest of World Installation & Services, and Global Products. Its electronic security systems comprise detection devices; asset protection and security administration systems; anti-theft systems; access control solutions, such as integrated security administration systems, access control solutions applications, alarm administration panels, door controllers, readers, keypads, and cards; video system solutions, such as digital video administration systems, matrix switchers and controllers, digital multiplexers, programmable cameras, monitors, and liquid crystal interactive displays; and burglar alarms and interactive security systems, such as alarm control panels, keypads, sensors, and central station receiving equipment for homes and businesses.
Molina Healthcare, Inc. (NYSE:MOH)’s shares dropped -0.03% to $76.33.
Molina Healthcare, Inc. (MOH) and Accountable Care Chicago, LLC, also known as MyCare Chicago, jointly declared recently that Molina Healthcare of Illinois, Inc., a wholly owned partner of Molina Healthcare, Inc., has reached a definitive agreement to acquire certain assets of the Medicaid business of MyCare Chicago. As a part of the transaction, Molina Healthcare of Illinois will receive the right to assume MyCare Chicago’s Medicaid members in Cook County, Illinois, as well as certain assets related to the operation of the Medicaid business. Molina Healthcare of Illinois will fund the transaction with accessible cash on hand. Subject to regulatory approvals and the satisfaction of other closing conditions, the closing of the transaction is predictable to occur during the fourth quarter of 2015.
Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program. The company operates through two segments, Health Plans and Molina Medicaid Solutions. The Health Plans segment operates health plans in 11 states. As of December 31, 2014, this segment served about 2.6 million members who were eligible for Medicaid, Medicare, and other government-sponsored health care programs.
At the end of Tuesday’s trade, Endo International plc - Ordinary Shares (NASDAQ:ENDP)‘s shares surged 4.92% to $76.59.
Endo International plc (ENDP) announced the appointment of Craig Paterson, M.D. as Chief Medical Officer. In this new role, Dr. Paterson will report to Susan Hall, Ph.D., Executive Vice President, Chief Scientific Officer and Global Head of Research & Development and Quality, and will be responsible for Endo’s global clinical development strategies, execution and lifecycle management as well as that all marketed products and assets under development meet the highest safety and quality standards. Prior to joining Endo, Dr. Paterson held senior level medical and clinical development positions at Salix Pharmaceuticals, King Pharmaceuticals and GlaxoSmithKline.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, counting Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain administration, urology, CNS disorders, immunosuppression, oncology, women’s health, hypertension, generic lidocaine patch, and other markets.
Gulfport Energy Corporation (NASDAQ:GPOR), ended its Tuesday’s trading session with 2.09% gain, and closed at $33.25.
Gulfport Energy Corporation (GPOR) declared the commencement of an underwritten public offering of 10,000,000 shares of its common stock, subject to market and other conditions. The underwriters will have a 30-day option to purchase up to an additional 1,500,000 shares from Gulfport. Gulfport intends to use the net proceeds from this offering (i) to fund a portion of the purchase price for the acquisition declared earlier recently of certain acreage and other assets in the Utica Shale in Ohio from American Energy—Utica, LLC and (ii) for general corporate purposes, counting the funding of a portion of its 2015 capital development plans.
The common stock will be issued and sold following an effective automatic shelf registration statement on Form S-3 formerly filed with the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. This offering may only be made by means of a prospectus supplement and related base prospectus.
Gulfport Energy Corporation engages in the acquisition, exploration, exploitation, and production of natural gas, natural gas liquids (NGLs), and crude oil in the United States. The company’s principal properties are located in the Utica Shale primarily in Eastern Ohio; Louisiana Gulf Coast in the West Cote Blanche Bay; and Hackberry fields. It also has interests in the Niobrara Formation of Northwestern Colorado; Bakken Formation; entities that operate in Southeast Asia, counting the Phu Horm gas field in Thailand; and Alberta oil sands located in Canada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
